fatty liver

Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to fatty liver

yellow discoloration as a result of the accumulation of certain fats (triglycerides) in the liver

Related Words

References in periodicals archive ?
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease that affects 20-30% of adults and 10% of children especially in industrialized countries, the prevalence of which is increasing all over the world.
Material and Methods: Seventy three adults of either gender were consecutively inducted after diagnosis of non alcoholic fatty liver disease (NAFLD) on ultrasonography (USG).
Scientists from the University of Haifa in Israel found that reduced brain volume was linked to non-alcoholic fatty liver disease (NAFLD).
Nonalcoholic fatty liver disease has been associated with an increased risk of cardiovascular disease independent of metabolic risk factors, such as diabetes, hypertension, and dyslipidemia.
Potential for Dietary I-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver Cancer.
Some people with fatty liver will develop cirrhosis, and those people have an increased risk of liver cancer.
This is the story of almost 80% of the patients visiting the doctors for ultrasound of their abdomen and are labelled to have fatty liver, where radiologist is the first health professional to counsel the patient regarding this normal to appear disease entity which has no drugs available for treatment and only patient can cure and prevent this disease process.
Among these criteria, deepbeam attenuation has presented better performance for diagnosing fatty liver disease.
We have seen angiogenic mechanisms and angiogenic genes in the pathophysiology of nonalcoholic fatty liver disease," said Dr.
While it's normal to have some fat in the liver, fatty liver or steatosis occurs when more than five to 10 percent of your liver weight is made up of fat.
The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled, parallel group study designed to evaluate the efficacy, safety and tolerability of VK2809 in approximately 80 patients with elevated LDL cholesterol (LDL-C) and non-alcoholic fatty liver disease.
More than one-third of adults in the US are obese, putting them at greater risk for conditions such as fatty liver disease -- caused by fatty deposits building up in the liver -- and atherosclerosis, the hardening and narrowing of the arteries.
Fatty liver or non-alcoholic fatty liver disease (NAFLD) is a range of conditions caused by a build-up of fat in the liver.
Hepatoprotective effect of licorice the root of Glycyrrhiza uralensis Fisher, in alcohol-induced fatty liver diseae.